Cargando…
Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604650/ https://www.ncbi.nlm.nih.gov/pubmed/37893244 http://dx.doi.org/10.3390/biomedicines11102736 |
| _version_ | 1785126885437472768 |
|---|---|
| author | Štorkánová, Hana Štorkánová, Lenka Navrátilová, Adéla Bečvář, Viktor Hulejová, Hana Oreská, Sabína Heřmánková, Barbora Špiritović, Maja Bečvář, Radim Pavelka, Karel Vencovský, Jiří Distler, Jörg H. W. Šenolt, Ladislav Tomčík, Michal |
| author_facet | Štorkánová, Hana Štorkánová, Lenka Navrátilová, Adéla Bečvář, Viktor Hulejová, Hana Oreská, Sabína Heřmánková, Barbora Špiritović, Maja Bečvář, Radim Pavelka, Karel Vencovský, Jiří Distler, Jörg H. W. Šenolt, Ladislav Tomčík, Michal |
| author_sort | Štorkánová, Hana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10604650 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106046502023-10-28 Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 Štorkánová, Hana Štorkánová, Lenka Navrátilová, Adéla Bečvář, Viktor Hulejová, Hana Oreská, Sabína Heřmánková, Barbora Špiritović, Maja Bečvář, Radim Pavelka, Karel Vencovský, Jiří Distler, Jörg H. W. Šenolt, Ladislav Tomčík, Michal Biomedicines Correction MDPI 2023-10-09 /pmc/articles/PMC10604650/ /pubmed/37893244 http://dx.doi.org/10.3390/biomedicines11102736 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Štorkánová, Hana Štorkánová, Lenka Navrátilová, Adéla Bečvář, Viktor Hulejová, Hana Oreská, Sabína Heřmánková, Barbora Špiritović, Maja Bečvář, Radim Pavelka, Karel Vencovský, Jiří Distler, Jörg H. W. Šenolt, Ladislav Tomčík, Michal Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title | Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title_full | Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title_fullStr | Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title_full_unstemmed | Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title_short | Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650 |
| title_sort | correction: štorkánová et al. inhibition of hsp90 counteracts the established experimental dermal fibrosis induced by bleomycin. biomedicines 2021, 9, 650 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604650/ https://www.ncbi.nlm.nih.gov/pubmed/37893244 http://dx.doi.org/10.3390/biomedicines11102736 |
| work_keys_str_mv | AT storkanovahana correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT storkanovalenka correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT navratilovaadela correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT becvarviktor correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT hulejovahana correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT oreskasabina correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT hermankovabarbora correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT spiritovicmaja correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT becvarradim correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT pavelkakarel correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT vencovskyjiri correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT distlerjorghw correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT senoltladislav correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 AT tomcikmichal correctionstorkanovaetalinhibitionofhsp90counteractstheestablishedexperimentaldermalfibrosisinducedbybleomycinbiomedicines20219650 |